序贯应用Southend巨细胞动脉炎概率评分与超声检查构建巨细胞动脉炎诊断预测模型:一项前瞻性多中心研究
这项前瞻性多中心起始队列研究纳入229例疑似新发巨细胞动脉炎患者,序贯联合Southend巨细胞动脉炎概率评分(SGCAPS)与定量超声指标构建预测模型。联合SGCAPS与晕环计数的HAS-GCA评分最为准确,乐观校正C统计量为0·969(95%CI 0·952至0·990),可将74%患者分入低或高概率组。作者结论认为该工具能可靠确认和排除巨细胞动脉炎,但需独立多中心研究证实。
要点
- HAS-GCA评分联合SGCAPS与晕环计数,乐观校正C统计量0·969(95%CI 0·952至0·990)。
- HAS-GCA评分将169/229例(74%)分入低或高概率组,低概率组105例中2例(2%)误分类,高概率组64例中2例(3%)误分类。
- 作者结论认为HAS-GCA评分可在快速通道门诊可靠确认和排除巨细胞动脉炎。
核心结论
- 作者认为联合SGCAPS与晕环计数的HAS-GCA评分可在快速通道门诊可靠确认和排除巨细胞动脉炎(与巨细胞动脉炎模仿者鉴别)。
- 作者指出这些发现需在独立的多中心研究中证实。
研究设计与样本
- 前瞻性、多中心、起始队列研究,纳入连续转诊至快速通道门诊的疑似新发巨细胞动脉炎患者,中心位于意大利、荷兰、西班牙和英国共七个中心。
- 最终临床诊断在6个月时确立,诊断时进行SGCAPS评估以及颞动脉和腋动脉定量超声检查(晕环计数、晕环评分、OMERACT巨细胞动脉炎评分[OGUS]三项评分)。
- 采用多变量逻辑回归分析构建预测模型,以SGCAPS与三项超声评分分别作为预测变量。
- 另在由5例患者和5名观察者组成的基于患者的可靠性练习中获取评分者间和评分者内可靠性的组内相关系数。
主要发现
- 2019年10月1日至2022年6月30日共招募并随访229例患者(150例[66%]女性,79例[34%]男性;平均年龄71岁[SD 10]),6个月时84例诊断为巨细胞动脉炎,145例诊断为巨细胞动脉炎模仿者(对照)。
- SGCAPS和全部三项超声评分均能良好区分巨细胞动脉炎患者与非巨细胞动脉炎患者。
- 可靠性练习显示三项超声评分的评分者间和评分者内可靠性均高。
- 联合SGCAPS与晕环计数的预测模型(称为HAS-GCA评分)最为准确,乐观校正C统计量为0·969(95%CI 0·952至0·990)。
- HAS-GCA评分可将229例中169例(74%)分入低概率组或高概率组,低概率组105例中2例(2%)误分类,高概率组64例中2例(3%)误分类;并制作了便于日常实践应用的名列图。
关键数值与推荐
- HAS-GCA评分联合SGCAPS与晕环计数,乐观校正C统计量0·969(95%CI 0·952至0·990)。
- HAS-GCA评分低概率组误分类2/105例(2%),高概率组误分类2/64例(3%)。
临床怎么用
- 作者认为HAS-GCA评分可在快速通道门诊可靠确认和排除巨细胞动脉炎(与巨细胞动脉炎模仿者鉴别),并制作了便于日常实践应用的名列图。
- 作者指出这些发现需在独立的多中心研究中证实。
局限性
- 作者指出这些发现需在独立的多中心研究中证实。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Giant cell arteritis is a critically ischaemic disease with protean manifestations that require urgent diagnosis and treatment. European Alliance of Associations for Rheumatology (EULAR) recommendations advocate ultrasonography as the first investigation for suspected giant cell arteritis. We developed a prediction tool that sequentially combines clinical assessment, as determined by the Southend Giant Cell Arteritis Probability Score (SGCAPS), with results of quantitative ultrasonography. METHODS: This prospective, multicentre, inception cohort study included consecutive patients with suspected new onset giant cell arteritis referred to fast-track clinics (seven centres in Italy, the Netherlands, Spain, and UK). Final clinical diagnosis was established at 6 months. SGCAPS and quantitative ultrasonography of temporal and axillary arteries with three scores (ie, halo count, halo score, and OMERACT GCA Score [OGUS]) were performed at diagnosis. We developed prediction models for diagnosis of giant cell arteritis by multivariable logistic regression analysis with SGCAPS and each of the three ultrasonographic scores as predicting variables. We obtained intraclass correlation coefficient for inter-rater and intra-rater reliability in a separate patient-based reliability exercise with five patients and five observers. FINDINGS: Between Oct 1, 2019, and June 30, 2022, we recruited and followed up 229 patients (150 [66%] women and 79 [34%] men; mean age 71 years [SD 10]), of whom 84 were diagnosed with giant cell arteritis and 145 with giant cell arteritis mimics (controls) at 6 months. SGCAPS and all three ultrasonographic scores discriminated well between patients with and without giant cell arteritis. A reliability exercise showed that the inter-rater and intra-rater reliability was high for all three ultrasonographic scores. The prediction model combining SGCAPS with the halo count, which was termed HAS-GCA score, was the most accurate model, with an optimism-adjusted C statistic of 0·969 (95% CI 0·952 to 0·990). The HAS-GCA score could classify 169 (74%) of 229 patients into either the low or high probability groups, with misclassification observed in two (2%) of 105 patients in the low probability group and two (3%) of 64 of patients in the high probability group. A nomogram for easy application of the score in daily practice was created. INTERPRETATION: A prediction tool for giant cell arteritis (the HAS-GCA score), combining SGCAPS and the halo count, reliably confirms and excludes giant cell arteritis from giant cell arteritis mimics in fast-track clinics. These findings require confirmation in an independent, multicentre study. FUNDING: Royal College of Physicians of Ireland, FOREUM.
引用
- Sebastian A, van der Geest KSM, Tomelleri A, et al. Development of a diagnostic prediction model for giant cell arteritis by sequential application of Southend Giant Cell Arteritis Probability Score and ultrasonography: a prospective multicentre study. Lancet Rheumatol. 2024. PMID: 38554720. doi:10.1016/S2665-9913(24)00027-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。